To test the efficacy of the muAd-Ifnα vector on the tumor microenvironment, we established an intravesical BLCA model by intravesical instillation of luciferase-tagged MB49 cells into the bladder of female mice (8 weeks old). The gene discussed is IFNA2; the disease is bladder transitional cell carcinoma.